Transient sleep apnea results in long-lasting increase in β-amyloid generation and tau hyperphosphorylation

Neurosci Res. 2024 Aug:205:40-46. doi: 10.1016/j.neures.2024.03.003. Epub 2024 Mar 19.

Abstract

Sleep apnea is regarded as an important risk factor in the pathogenesis of Alzheimer disease (AD). Chronic intermittent hypoxia treatment (IHT) given during the sleep period of the circadian cycle in experimental animals is a well-established sleep apnea model. Here we report that transient IHT for 4 days on AD model mice causes Aβ overproduction 2 months after IHT presumably via upregulation of synaptic BACE1, side-by-side with tau hyperphosphorylation. These results suggest that even transient IHT may be sufficient to cause long-lasting changes in the molecules measured as AD biomarkers in the brain.

Keywords: Alzheimer; Chronic intermittent hypoxia; Disease (AD); Hyperphosphorylation; Sleep apnea; Sleep-disordered breathing; Tau; β-Secretase 1 (BACE1).

MeSH terms

  • Alzheimer Disease / metabolism
  • Amyloid Precursor Protein Secretases / metabolism
  • Amyloid beta-Peptides* / metabolism
  • Animals
  • Brain / metabolism
  • Disease Models, Animal*
  • Hypoxia / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Phosphorylation
  • Sleep Apnea Syndromes* / metabolism
  • Sleep Apnea Syndromes* / physiopathology
  • tau Proteins* / metabolism

Substances

  • tau Proteins
  • Amyloid beta-Peptides
  • Amyloid Precursor Protein Secretases